Akari Therapeutics Reports First Quarter 2019 Financial Results And Highlights Recent Clinical Progress

NEXT STORY
Kintai Therapeutics Announces Formation of World-Class Scientific Advisory Board
PREV STORY
TYME Provides Business Update and Reports Fourth Quarter and Fiscal Year 2019 Financial and Operating Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Vaxil Provides Update of Conversion of Previously Issued Convertible Debt and the Granting of Options

author_avatar
NASDAQ Market News

Genmab Announces Data to be Presented at SITC 35th Anniversary Annual Meeting

author_avatar
NASDAQ Market News

Avalo to Present at the Jefferies Virtual Next Generation IBD Therapeutics Summit

author_avatar
NASDAQ Market News